Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.53 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.51 |
| ▸ | PDE4A | P27815 | 5/20 | 0.51 |
| ▸ | PDE4B | Q07343 | 5/20 | 0.51 |
| ▸ | PDE4C | Q08493 | 5/20 | 0.51 |
| ▸ | PDE4D | Q08499 | 5/20 | 0.51 |
| ▸ | ADORA2B | P29275 | 4/20 | 0.51 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.51 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.51 |
| ▸ | ALPL | P05186 | 1/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.51 |
| ▸ | TMIGD3 | P0DMS9 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | PNP | P00491 | 1/20 | 0.49 |
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL27738785 | 0.98 | ADORA2A (0.54) | ATAD2ADORA2APDE4APDE4BPDE4C | |
| Hydrochloric Acid SCHEMBL27339406 | 0.98 | ATAD2 (0.51) | ATAD2ADORA2APDE4APDE4BPDE4C | |
| SCHEMBL27602647 | 0.95 | ATAD2 (0.49) | ATAD2ADORA2APDE4APDE4BPDE4C | |
| Thiophene SCHEMBL27638390 | 0.90 | ATAD2 (0.44) | ATAD2ADORA2APDE4APDE4BPDE4C | |
| Oxazole SCHEMBL27309879 | 0.85 | ATAD2 (0.40) | ATAD2ADORA2APDE4APDE4BPDE4C | |
| Hydrochlorthiazide SCHEMBL27456436 | 0.85 | ATAD2 (0.40) | ATAD2ADORA2APDE4APDE4BPDE4C | |
| SCHEMBL27310857 | 0.83 | MGMT (0.41) | ATAD2ADORA2APDE4APDE4BPDE4C | |
| SCHEMBL28106050 | 0.83 | ATAD2 (0.39) | ATAD2ADORA2APDE4APDE4BPDE4C | |
| SCHEMBL17200149 | 0.83 | CRBN (0.41) | ATAD2ADORA2APDE4APDE4BPDE4C | |
| SCHEMBL41788 | 0.81 | PNP (0.50) | ATAD2ADORA2APDE4APDE4BPDE4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 27761 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026106497-A2 | FUNCTIONALIZED CIRCULAR RNA AND METHODS AND INTERMEDIATES FOR THEIR PRODUCTION | SIEĆ BADAWCZA ŁUKASIEWICZ – PORT POLSKI OSRODEK ROZWOJU TECHNOLOGII (PL) | 2026-05-21 | — | — | WO | claimed |
| WO-2026099790-A1 | DEVICE USING ALTERNATING ELECTRIC FIELDS | NOVOCURE GMBH (CH) | 2026-05-15 | — | — | WO | claimed |
| US-20260131157-A1 | METHODS OF USING ALTERNATING ELECTRIC FIELDS | NOVOCURE GMBH (CH) | 2026-05-14 | — | — | US | claimed |
| US-20260115161-A1 | 2-HYDROXY-OCTADECENE-9-CIS-OATE FOR USE IN THE TREATMENT OF ONCOLOGICAL PATHOLOGIES AND NEUROPATHIC PAIN | LAMINAR PHARMACEUTICALS S A (ES) | 2026-04-30 | — | — | US | claimed |
| US-12577554-B2 | Methods for purification of messenger RNA | TRANSLATE BIO, INC. (US) | 2026-03-17 | — | — | US | claimed |
| US-12569572-B2 | Messenger RNA therapy for the treatment of Friedreich's ataxia | TRANSLATE BIO, INC. (US) | 2026-03-10 | — | — | US | claimed |
| US-12552858-B2 | Methods and compositions for delivering mRNA coded antibodies | TRANSLATE BIO, INC. (US) | 2026-02-17 | — | — | US | claimed |
| EP-4663187-A1 | 2-HYDROXY-OCTADECENE-9-CIS-OATE FOR USE IN THE TREATMENT OF ONCOLOGICAL PATHOLOGIES AND NEUROPATHIC PAIN | Laminar Pharmaceuticals, S.A. (ES) | 2025-12-17 | — | — | EP | claimed |
| EP-4659246-A1 | ELECTROCHEMICAL SYNTHESIS WITH REDOX STABLE NUCLEOTIDES | Atlas Data Storage, Inc. (US) | 2025-12-10 | — | — | EP | claimed |
| US-20250368986-A1 | ELECTROCHEMICAL SYNTHESIS WITH REDOX STABLE NUCLEOTIDES | ATLAS DATA STORAGE INC (US) | 2025-12-04 | — | — | US | claimed |
| WO-1996003653-A1 | SUPERPARAMAGNETIC PARTICLES, PROCESS FOR THEIR PRODUCTION AND THEIR USE | SILICA GEL GES.MBH ABSORPTIONSTECHNIK, APPARATEBAU (DE) | 1996-02-08 | — | — | WO | claimed |
| EP-0689430-A1 | SUPERPARAMAGNETIC PARTICLES, PROCESS FOR PRODUCING THE SAME AND THEIR USE | SILICA GEL GMBH (DE) | 1996-01-03 | — | — | EP | claimed |
| EP-0625985-A1 | METHOD AND RING-OPENED PURINE COMPOUNDS FOR LABELING POLYNUCLEOTIDES. | UNIV MIAMI (US) | 1994-11-30 | — | — | EP | claimed |
| WO-1994021240-A2 | SUPERPARAMAGNETIC PARTICLES, PROCESS FOR PRODUCING THE SAME AND THEIR USE | SILICA GEL GES.M.B.H (DE) | 1994-09-29 | — | — | WO | claimed |
| WO-1993011146-A1 | METHOD AND RING-OPENED PURINE COMPOUNDS FOR LABELING POLYNUCLEOTIDES | UNIVERSITY OF MIAMI (US) | 1993-06-10 | — | — | WO | claimed |
| EP-0540693-A1 | THE REDUCTION OF NON-SPECIFIC AMPLIFICATION DURING $i(IN VITRO) NUCLEIC ACID AMPLIFICATION USING MODIFIED NUCLEIC ACID BASES | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1993-05-12 | — | — | EP | claimed |
| US-5160725-A | Contrast agent for diagnostic imaging, polyethylene glycol phosphates and carboxylates as stabilizers | SILICA GEL GESELLSCHAFT MBH ADSORPTIONS-TECHNIK, APPARATEBAU (DE) | 1992-11-03 | — | — | US | claimed |
| EP-0284549-B1 | MAGNETIC FLUID COMPOSITIONS | Silica Gel Ges.mbH Absorptionstechnik, Apparatebau (DE) | 1992-07-15 | — | — | EP | claimed |
| WO-1992001814-A2 | THE REDUCTION OF NON-SPECIFIC AMPLIFICATION DURING IN VITRO NUCLEIC ACID AMPLIFICATION USING MODIFIED NUCLEIC ACID BASES | F. HOFFMANN-LA-ROCHE AG (CH) | 1992-02-06 | — | — | WO | claimed |
| EP-0284549-A2 | Magnetic fluid compositions | Silica Gel Ges.mbH Absorptionstechnik, Apparatebau (DE) | 1988-09-28 | — | — | EP | claimed |